Menu
Recruiting NCT06150482

Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study

— Observational Liver Cirrhosis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No intervention.
Who it may be relevant to
Registry conditions: Liver Cirrhosis. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Netherlands
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Multicenter, retrospective cohort study investigating healthcare utilization in compensated and decompensated liver cirrhosis patients, including disease course and characteristics associated with healthcare utilization and, for example psychosocial factors.

Interventions

  • Other No intervention
    No intervention

Primary outcome measures

  • Number of liver cirrhosis related outpatient contacts before liver cirrhosis complications [Time frame: 2 years before complication, death or loss to follow-up]
  • Number of liver cirrhosis related radiographic imaging before liver cirrhosis complications [Time frame: 2 years before complication, death or loss to follow-up]
  • Number of liver cirrhosis related esophagogastroscopies before liver cirrhosis complications [Time frame: 2 years before complication, death or loss to follow-up]
  • Number of liver cirrhosis related elastographies before liver cirrhosis complications [Time frame: 2 years before complication, death or loss to follow-up]

Eligibility criteria

Inclusion criteria

  • Patients ≥ 18 years of age
  • Liver cirrhosis, based on biopsy, fibroscan or diagnostic imaging data

Exclusion criteria

  • Known malignancy with hepatic metastasis at baseline
  • Liver transplantation at baseline

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Netherlands · 2 centers
  • Gelre Ziekenhuizen — Apeldoorn
  • Maastricht University Medical Center — Maastricht

Identifiers

NCT: NCT06150482 · 2021-2857-A-2

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗